Overview Corever in the Treatment of Hypertension Status: Completed Trial end date: 2016-08-01 Target enrollment: Participant gender: Summary The study primarily aims to compare the effects of two doses of Corever with placebo in patients with hypertension. Phase: Phase 3 Details Lead Sponsor: TSH Biopharm Corporation Limited